Five-minute preparation of platelet-poor plasma for routine coagulation testing
RésuméClinical and Laboratory Standard Institute guidelines require that routine coagulation tests are performed with platelet-poor plasma [< 10 000 platelets/microL] and prepared from whole citrated blood centrifuged at low speed for 10-30 minutes. To compare results obtained from plasma centrifuged for 5 minutes at 3000 g or for 10 minutes at 2000 g, 46 blood samples from normal healthy adults were assayed for prothrombin time, international normalized ratio and activated partial thromboplastin time. No significant differences were found in test results and it was concluded that 5 minutes centrifugation at 3000 g is a reliable and useful option to reduce the turnaround time for these tests
Sultan, A. (2010). Five-minute preparation of platelet-poor plasma for routine coagulation testing. http://www.who.int/iris/handle/10665/117849
EMHJ - Eastern Mediterranean Health Journal, 16 (2), 233-236, 2010
MétadonnéesAfficher la fiche complète
Affichage des documents associés par titre, auteur, créateur et sujet.
Message from, Dr Hussein A. Gezairy, Regional Director, WHO Eastern Mediterranean Region, to the regional consultation for quality assurance, and safety of plasma and plasma derivatives, Cairo, Egypt, 31 January-3 February 2005 World Health Organization, Regional Office for the Eastern Mediterranean (2005)
Effect of quinine therapy on plasma glucose and plasma insulin levels in pregnant women infected with Plasmodium falciparum malaria in Gezira state Elbadawi, N.E.E.; Mohamed, M.I.; Dawod, O.Y.; Ali, K.E.; Daoud, O.H.; Ali, E.M.; Ahmed, E.G.E.; Mohamed, A.E. (2011)To determine if quinine has a metabolic effect during treatment of severe or complicated malaria, we studied its effects on plasma glucose and plasma insulin levels in 150 pregnant women with malaria referred to Madani maternity teaching hospital, Gezira state and 50 healthy pregnant controls. Levels were determined at baseline [day 0] before the start of quinine treatment, after 2 days of treatment [2 hours after the 4th dose] and after 7 days of treatment [day 8]. There was a statistically significant increase in plasma insulin concentrations ...
WHO Global Programme on AIDS; League of Red Cross Societies; Global Blood Safety Initiative; World Health Organization. Health Laboratory Technology Unit (WHO/GPA/INF/89.17WHO/LAB/89.9. Unpublished, 1989)